This is a preview of subscription content, log in via an institution to check access.
Reference
Denham JW, et al. Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial. Lancet Oncology : 9 Nov 2012. Available from: URL: http://dx.doi.org/10.1016/S1470-2045%2812%2970423-0
Rights and permissions
About this article
Cite this article
Long-term leuprorelin has adverse effect on some PROs. PharmacoEconomics & Outcomes News 668, 8 (2012). https://doi.org/10.1007/s40274-012-0024-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-012-0024-8